Cholesterol extraction from pancreatic beta cells has previously been shown to disrupt the internalisation, clustering and cAMP responses of the glucagon-like peptide-1 receptor (GLP-1R), a class B1 GPCR with key roles in the control of blood glucose levels via the potentiation of insulin secretion in beta cells and weight reduction via the modulation of brain appetite control centres
Importantly, none of the studies reported any worsening of headaches with GLP-1 RAs
We show in the Data S1 that switching from q1wk to q2wk increases the peaktotrough difference in drug concentration by 9% for tirzepatide and 34% for semaglutide
1 High-risk individuals with FIB-4 values above 2.67 should be referred directly to hepatology
Whilst the 3T3-L1 mouse pre-adipocyte cell line is extensively utilised for identifying adipogenic chemicals, and it is easier to use a cell line, rather than primary cells, the species relevance with respect to induction of human adipogenesis is weaker
What is a standard dose of a GLP-1 drug